Strategic partnerships are beneficial to companies within the medical device industry because they increase brand recognition and provide marketing opportunities. QuidelOrtho began partnering with professional and collegiate sports teams during the COVID-19 pandemic with the goal of increasing its brand recognition. While QuidelOrtho’s partnerships with sports teams are not … [Read more...]
ECG Testing in Primary Care
In the United States, someone has a heart attack every 40 seconds. Cardiovascular disease is America’s costliest disease. And, by 2035, direct medical costs of cardiovascular diseases are projected to be at least $749 billion. In this Repertoire podcast, Brooke Griesdorn, Associate Marketing Manager at Midmark shared several reasons why ECG testing in primary care is … [Read more...]
Mergers, Acquisitions, and Respiratory season with Quidel
With COVID, flu and RSV all making headlines, this year’s respiratory season promises to be one for the ages. One market leader ready to meet that demand is QuidelOrtho. The diagnostics company has undergone a transformation during the past few years with its acquisition of some Alere business and a merger with Ortho. In a recent podcast, Repertoire Publisher Scott Adams … [Read more...]
The acquisition of Hillrom by Baxter and The Future of Frontline Care
Welch Allyn is a recognizable, respected brand in the healthcare arena, with deep ties to clinicians and physicians starting medical school. “Welch Allyn has an enormous brand equity with providers because of that familiarity and trust, going all the way back to the experiences they first had in med school and then the experiences they have with the products later in their … [Read more...]
Understanding and Improving the PIVC Market
As a standard medical practice, clinicians are familiar with the sticky subject of IV catheters. This therapy has been used for over 350 years, but it certainly provides challenges for plenty of clinicians in the field. Studies have shown that insertion on the first attempt was unsuccessful in up to 26% of adult patients, 54% of pediatric patients, and 55% of neonatal patients. … [Read more...]
Increase Your Lab Sales in 2023
Vaginitis and vaginosis are responsible for over 10 million visits per year to physician offices by women in the U.S. In this podcast, Repertoire publisher Scott Adams speaks to Cisco Merrill, national sales director, alternate site for Cepheid about the molecular diagnostic company’s entry into the sexual health market with its Xpert® Xpress MVP test. The Xpert Xpress MVP … [Read more...]
Driving Value Through Clinical Education
In this podcast, Repertoire Magazine’s Scott Adams spoke to B. Braun’s Brett Sarnoff and Aime Lenz about driving value in healthcare through clinical education with consistent peripheral intravenous catheter (PIVC) care. PIVC restarts can subject patients to discomfort and risk of infection and other complications but only 57% or less of nursing students receive any form of … [Read more...]
Scott Adams Interviews NASCAR driver Will Rodgers on his Liver Health Foundation
Will Rodgers competes on the NASCAR circuit, despite managing an underlying liver condition. As a young child, Rodgers was diagnosed with primary sclerosing cholangitis (PSC), a chronic liver disease caused by progressive inflammation and scarring of the bile ducts of the liver. While he’s been living healthy for over 20 years, going through that experience, and knowing he … [Read more...]
The Value of Vitals and ECG Testing in Primary Care
In this episode of Repertoire Podcast, host and Repertoire Publisher Scott Adams sat down with Kylie Gilberg, the marketing manager for the Midmark digital diagnostic product category, to discuss the importance of accurate vital signs checks and ECG testing in primary care. Gilberg said, “There are a lot of different areas of clinical care that we can take into … [Read more...]
QuidelOrtho provides easier, faster test results with new molecular platform
In this Repertoire Podcast, Repertoire Magazine publisher Scott Adams is joined by Tammi Ranalli, the Senior Vice President of Molecular Diagnostics for the QuidelOrtho Corporation to discuss QuidelOrtho's new molecular diagnostic innovation, the Savanna. "This has really been an over 10-year labor of love for me," Ranalli said about the new cartridge-based … [Read more...]